Delisted SPAC Metal Sky Star (MSSA) faces liquidation risk with $861,784 trust, deadline Jan 5, 2026

Snapshot - Metal Sky Star Acquisition Corporation (NASDAQ: MSSA)

What's happening: MSSA is a blank‑check (SPAC) that has not completed a business combination. Nasdaq determined the company failed to complete a business combination within the 36‑month deadline and its securities were delisted (Form 25‑NSE filed July 14, 2025). The company now trades on the OTC market, has nil cash outside the trust, a sharply reduced trust balance, material internal control weaknesses, and continued sponsor support via promissory notes and extension payments while it seeks a deal before the extended deadline (January 5, 2026).

Key points & statistics
* Total assets: $863,188 (June 30, 2025) vs $6,683,844 (Dec 31, 2024).
* Marketable securities held in trust account: $861,784 (Jun 30, 2025) vs $6,677,519 (Dec 31, 2024).
* Total liabilities: $7,848,645 (Jun 30, 2025).
* Accrued expenses: $507,441; Due to related parties: $1,418,801; Promissory notes-related party: $3,047,403 (Jun 30, 2025).
* Ordinary shares subject to possible redemption: 60,523 shares at redemption value $14.24 → $861,784 recorded as temporary equity.
* Shareholders' deficit: $(7,847,241) (Jun 30, 2025). Accumulated deficit: $(7,850,446).
* Working capital deficit: $4,972,241 (company disclosure).
* Cash outside trust: nil as of Jun 30, 2025; cash withdrawn from trust to redeem public shares: $6,139,261 (six months ended Jun 30, 2025).
* Q2 2025 operating (formation & operational) expenses: $225,904 vs $74,148 (Q2 2024).
* Q2 2025 other income (trust): realized interest $25,052; unrealized gain $2,832; net loss Q2 2025: $(198,020) (vs net income $392,165 Q2 2024).
* Six months ended Jun 30, 2025: net loss $(351,198); interest earned $95,694; unrealized gain $2,832 (vs net income $689,185 in six months 2024).
* Net loss per non‑redeemable share (basic & diluted): Q2 2025 $(0.09) vs Q2 2024 $(0.03); six months 2025 $(0.19) vs $(0.08) prior year.
* Material weaknesses in internal control over financial reporting disclosed (Dec 31, 2024) - ineffective review/approval of journal entries, lack of segregation of duties.

Positive aspects (income statement / operations)
* Trust continues to generate interest income: $95,694 in the six months ended Jun 30, 2025 (some interest is reinvested into the trust).
* Sponsor active in supporting extensions and funding: promissory note facility in place (balance $3,047,403 at Jun 30, 2025) and subsequent increases/drawdowns disclosed as events (Sponsor paid $101,125 in operating expenses post‑period; promissory note capacity later increased per filing).
* Management obtained shareholder approvals to extend business combination deadline to January 5, 2026, giving additional runway (subject to continued funding and redemptions).

Negative aspects (income statement / operations)
* Operating costs rising - formation & operational costs increased to $225,904 in Q2 2025 (from $74,148 in Q2 2024), pressuring limited non‑operating income.
* Net loss in Q2 2025 of $(198,020) and six‑month loss $(351,198) vs material net income in comparable 2024 periods - primarily due to much lower trust income following redemptions/withdrawals.
* Trust income and unrealized gains dropped sharply year‑over‑year (other income Q2 2025 $27,884 vs $466,313 Q2 2024) as the trust balance fell from $6.68M to $861,784.
* No operating revenue expected until a business combination is completed - ongoing losses are financed through related‑party loans and sponsor support, increasing related‑party exposure and leverage.
* Nil cash outside trust and a working capital deficit ($4.97M) create immediate liquidity strain; mandatory liquidation is possible if a business combination fails by the extended deadline.
* Internal control material weaknesses raise risk of misstatements and may impair investor confidence and deal execution.

Bottom line / Near‑term watch items
* Primary risk: failure to complete a business combination by the extended deadline (Jan 5, 2026) would trigger mandatory liquidation and dissolution - this remains the company's existential risk.
* Liquidity is dependent on sponsor loans and extension payments; trust balance is low ($861,784). Promissory note balance and related‑party payables are large relative to assets.
* Positive: sponsor has provided funding and extensions so far; interest income still exists but is insufficient to cover growing operational costs.
* Actionable signals to monitor: updates on completed business combination(s), additional sponsor funding or financing, changes to trust balance, any appeal/reversal of delisting (unlikely), remediation of internal control weaknesses.

Short takeaway: MSSA remains a SPAC without a completed deal, was delisted from Nasdaq, and faces severe liquidity and control challenges. Sponsor support and the extension to Jan 5, 2026 provide limited runway, but the company's reduced trust balance ($861,784), working capital deficit ($4,972,241), rising operating costs, and material internal control weaknesses make the outcome highly binary - either a combination is closed with new capital or liquidation/dissolution becomes likely.